Ebglyss — Potential achievements
Products & Services · Potential achievementsEli Lilly Ebglyss — Potential achievements decreased by 4.0% to $1.20B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.0%, from $1.25B to $1.20B. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ4 2023
Last reportedQ4 2025
How to read this metric
An increase suggests higher market adoption and successful commercial execution, while a decrease may indicate competitive pressure or slower-than-expected market uptake.
Detailed definition
This metric represents the projected or estimated revenue contribution and market performance potential for a specific p...
Peer comparison
Comparable to peak sales estimates or revenue guidance for specific blockbuster drug assets at other major pharmaceutical companies.
Metric ID:
lly_segment_ebglyss_potential_achievementsHistorical Data
9 periods
| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $1.25B | $1.25B | $1.25B | $1.25B | $1.25B | $1.25B | $1.25B | $1.25B | $1.20B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -4.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | -4.0% |
Range$1.20B – $1.25B
CAGR-2.0%
Avg YoY Growth-0.8%
Median YoY Growth+0.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's ebglyss — potential achievements?
- Eli Lilly (LLY) reported ebglyss — potential achievements of $1.20B in Q4 2025.
- How has Eli Lilly's ebglyss — potential achievements changed year-over-year?
- Eli Lilly's ebglyss — potential achievements decreased by 4.0% year-over-year, from $1.25B to $1.20B.
- What does ebglyss — potential achievements mean?
- The estimated future revenue potential for a specific drug product line.